Compare ZG & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZG | HOLX |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | United States | United States |
| Employees | 7068 | N/A |
| Industry | Business Services | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 16.9B |
| IPO Year | N/A | 1995 |
| Metric | ZG | HOLX |
|---|---|---|
| Price | $47.74 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 26 | 13 |
| Target Price | ★ $79.82 | $77.89 |
| AVG Volume (30 Days) | 856.3K | ★ 11.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $17.77 | $4.74 |
| Revenue Next Year | $13.25 | $5.03 |
| P/E Ratio | $499.11 | ★ $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $39.14 | $51.90 |
| 52 Week High | $90.22 | $76.07 |
| Indicator | ZG | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 63.45 | 69.09 |
| Support Level | $41.00 | $75.10 |
| Resistance Level | $49.24 | N/A |
| Average True Range (ATR) | 1.89 | 0.19 |
| MACD | 1.02 | 0.03 |
| Stochastic Oscillator | 97.04 | 95.19 |
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.